Surrozen, Inc. (SRZN)
19.96
-0.72
(-3.48%)
USD |
NASDAQ |
Sep 09, 16:00
19.96
0.00 (0.00%)
After-Hours: 17:10
Surrozen Total Assets (Quarterly) : 115.61M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 115.61M |
| March 31, 2026 | 120.71M |
| December 31, 2025 | 98.73M |
| September 30, 2025 | 94.05M |
| June 30, 2025 | 102.70M |
| March 31, 2025 | 114.83M |
| December 31, 2024 | 48.47M |
| September 30, 2024 | 48.00M |
| June 30, 2024 | 45.07M |
| March 31, 2024 | 36.72M |
| December 31, 2023 | 46.08M |
| September 30, 2023 | 53.97M |
| Date | Value |
|---|---|
| June 30, 2023 | 64.00M |
| March 31, 2023 | 74.20M |
| December 31, 2022 | 89.44M |
| September 30, 2022 | 91.43M |
| June 30, 2022 | 104.13M |
| March 31, 2022 | 117.66M |
| December 31, 2021 | 137.17M |
| September 30, 2021 | 150.64M |
| June 30, 2021 | 92.95M |
| March 31, 2021 | 93.44M |
| December 31, 2020 | 62.06M |
| September 30, 2020 | 0.0507M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 334.27M |
| Shareholders Equity (Quarterly) | -218.66M |
| Debt to Equity Ratio | -0.0289 |
| Current Ratio | 12.14 |
| Net Debt Paydown Yield | 0.11% |